Surface Modified Glucose‐Derived, Blood–Brain Barrier‐Crossing Nanospheres Dually Targets Macrophage and Cancer Cells for Effective In Situ Anti‐Glioma Effect DOI
Madhan Mohan Chandra Sekhar Jaggarapu, Aasia Ansari, Sudhakar Jinka

и другие.

Advanced Therapeutics, Год журнала: 2024, Номер unknown

Опубликована: Авг. 9, 2024

Abstract Glucose‐derived carbon nanospheres (CSP), uniquely derived by hydrothermal condensation process, inherently cross blood–brain‐barrier (BBB) but distribute all over the brain. Albeit its potential to treat glioma as an effective drug delivery system, it is challenging restrict drug‐associated CSP within region and reduce non‐specific side effects. Incidentally, gliomas moderately express sigma receptors (SR). Earlier, a cationic lipid‐conjugated neuropsychotic drug, haloperidol (H8) developed with SR‐targetability anticancer effect zero BBB‐crossing ability. In this study, surface modified H8 (CH8 nano‐conjugate) dual targeting achieved glioma‐tumor microenvironment: 1) cells 2) pro‐proliferative M2 tumor‐associated macrophages (TAM), both SR. CH8‐treatment increases survivability of orthotopic bearing mice significantly reduces tumor burden in glioma‐subcutaneous model. Further CH8‐surface combining brain carmustine (CH8‐CRM). CH8‐CRM nano‐conjugate selectively enhances glioma‐carrying aggressiveness comparison other treatment groups. Lysates from CH8‐CRM‐treated show upregulation cleaved‐caspase 3, p53, downregulation pAkt. The combination pronouncedly anti‐glioma H8. Conclusively, CH8‐mediated dual‐targeting via SR glioma‐associated exemplifies repurposing drugs for treating glioma.

Язык: Английский

Recent advances on the application of nanobiomimetic structures as drug delivery systems DOI
Seyyed Behnam Abdollahi Boraei,

Sadaf Javadpour,

Fatemeh Kamali Nejad

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер 100, С. 106009 - 106009

Опубликована: Июль 31, 2024

Язык: Английский

Процитировано

2

Sol-Gel Immobilization of Colistin Sulfate onto Double Walled Carbon Nanotubes: In Vitro Bone Bioactivity DOI Creative Commons
Ahmed A. Haroun,

Fathalla Ayoob,

Ragab A. Masoud

и другие.

Nano Biomedicine and Engineering, Год журнала: 2024, Номер 16(3), С. 498 - 509

Опубликована: Июль 2, 2024

The aim of this study is to fabricate a multifunctional biohybrid composite utilizing double walled carbon nanotubes (DWCNTs) as carrier for loading the colistin sulfate (CLS) through application sol-gel technique. resulting was analyzed by Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), scanning electron microscope (SEM), X-ray diffraction patterns (XRD), and particle size distribution dynamic light scattering technique (DLS). Furthermore, an assessment in vitro bone bioactivity conducted under physiological levels Ca2+ PO4+ (SBF) at 37 °C pH 7.4 over period 7 days. Additionally, cytotoxicity against mice marrow cells evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. outcomes indicated that possessed 365 nm in diameter with PDI 0.21 (the pure CLS untreated DWCNTs were 290 459 diameter, respectively), improved biocompatibility, promoted formation Ca-phosphate apatite layer on surface Ca/P ratio approximately 1.78. findings collectively validated significant contribution peptide DWCNTs-based purposes tissue engineering.

Язык: Английский

Процитировано

1

Biocompatible Nanomaterials for Sustainable Biomedical Applications DOI Creative Commons
Amit Dutt,

Neha Saini,

Akhilesh Kalia

и другие.

E3S Web of Conferences, Год журнала: 2024, Номер 547, С. 03020 - 03020

Опубликована: Янв. 1, 2024

We explore the many ways biocompatible nanomaterials may be used in sustainable biomedical settings. Quantum dots are 10 nm size, carbon nanotubes 50 nm, iron oxide nanoparticles 25 gold 20 and silver 30 nm. The physicochemical features of these different from one another. These encapsulate therapeutic substances, according to drug loading evaluations; for example, can hold 15 mg/g oxide, 12 silver, 18 nanotubes, carbon, quantum dots. Nanoparticles (95% vitality after 24 hours), (93% viability), (97% (92% (90% viability) highlight biocompatibility materials. Fluorescence intensities 1000 AU nanoparticles, 980 1050 900 1100 were observed vivo imaging investigations, further demonstrating potential as contrast agents. By conducting thorough assessments analyses, this study reveals how create long-term applications, such molecular targeted delivery, which will improve healthcare solutions patient outcomes.

Язык: Английский

Процитировано

1

Nano‐Enhanced Polymer Composite Materials: A Review of Current Advancements and Challenges DOI Open Access
Abdulrahman Adeiza Musa, Abdulhakeem Bello,

Mohammed Adam Sani

и другие.

Опубликована: Июль 26, 2024

Nanomaterials have shown significant promise for enhancing the performance of composite materials and increasing their functionality various industrial applications. This review explores unique properties nanomaterials, particularly carbon-based provides key findings in utilizing them to enhance performance. It highlights specific nano-based potential advancing field nanocomposites. Challenges associated with nanocomposite production utilization are also discussed, along possible solutions address them. Finally, study recommendations continued research innovation nanocomposites fully unlock benefits these advanced broader future

Язык: Английский

Процитировано

1

Surface Modified Glucose‐Derived, Blood–Brain Barrier‐Crossing Nanospheres Dually Targets Macrophage and Cancer Cells for Effective In Situ Anti‐Glioma Effect DOI
Madhan Mohan Chandra Sekhar Jaggarapu, Aasia Ansari, Sudhakar Jinka

и другие.

Advanced Therapeutics, Год журнала: 2024, Номер unknown

Опубликована: Авг. 9, 2024

Abstract Glucose‐derived carbon nanospheres (CSP), uniquely derived by hydrothermal condensation process, inherently cross blood–brain‐barrier (BBB) but distribute all over the brain. Albeit its potential to treat glioma as an effective drug delivery system, it is challenging restrict drug‐associated CSP within region and reduce non‐specific side effects. Incidentally, gliomas moderately express sigma receptors (SR). Earlier, a cationic lipid‐conjugated neuropsychotic drug, haloperidol (H8) developed with SR‐targetability anticancer effect zero BBB‐crossing ability. In this study, surface modified H8 (CH8 nano‐conjugate) dual targeting achieved glioma‐tumor microenvironment: 1) cells 2) pro‐proliferative M2 tumor‐associated macrophages (TAM), both SR. CH8‐treatment increases survivability of orthotopic bearing mice significantly reduces tumor burden in glioma‐subcutaneous model. Further CH8‐surface combining brain carmustine (CH8‐CRM). CH8‐CRM nano‐conjugate selectively enhances glioma‐carrying aggressiveness comparison other treatment groups. Lysates from CH8‐CRM‐treated show upregulation cleaved‐caspase 3, p53, downregulation pAkt. The combination pronouncedly anti‐glioma H8. Conclusively, CH8‐mediated dual‐targeting via SR glioma‐associated exemplifies repurposing drugs for treating glioma.

Язык: Английский

Процитировано

1